These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 309222)

  • 1. [Tumor immunologic aspects in the diagnosis and treatment of malignant bone tumors].
    Warnatz H
    Z Orthop Ihre Grenzgeb; 1978 Aug; 116(4):. PubMed ID: 309222
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of allograft rejection.
    Hamburger J
    Trans Am Soc Artif Intern Organs; 1976; 22():729-33. PubMed ID: 781987
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic aspects of malignant tumors.
    Ariyan S
    Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R; Urban K
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
    Ablin RJ
    Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic factors in the growth of malignant tumors].
    Adolphs HD
    Med Klin; 1976 Feb; 71(9):353-64. PubMed ID: 768731
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental active immunization in inbred mice].
    Stein D; Wolf M
    Z Exp Chir; 1978; 11(2):134-8. PubMed ID: 306714
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity in rheumatoid arthritis.
    Jiménez López A; Olmos Martínez JM
    Allergol Immunopathol (Madr); 1982; 10(6):471-9. PubMed ID: 6762823
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
    Perlmann P; O'Toole C; Unsgaard B
    Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
    [No Abstract]   [Full Text] [Related]  

  • 13. Nutrition and tumor immunity: divergent effects of antitumor antibody.
    Bull DM
    Cancer Res; 1975 Nov; 35(11 Pt. 2):3317-9. PubMed ID: 1104143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific T cell-dependent, antigen-antibody mediated suppression of macrophages: abrogation by nonspecifically stimulated T cells.
    Rao VS; Mokyr MB; Gershon RK; Mitchell MS
    J Immunol; 1977 Jun; 118(6):2117-24. PubMed ID: 325141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transplantation and antineoplastic immunity in bone pathology (an analysis of the blocking factor)].
    Govallo VI
    Ortop Travmatol Protez; 1974 Jul; (7):1-6. PubMed ID: 4548176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
    Mitchell MS; Mokyr MB; Goldwater DJ
    Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human B- and T-lymphocyte response in vitro with serum from rabbits immunized with antibody-coated autologous or allogeneic cells.
    Weimer R; Terness P; Opelz G
    Transplant Proc; 1987 Oct; 19(5):4289-93. PubMed ID: 3499693
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic aspects of lung cancer.
    Morton DL; Holmes EC; Golub SH
    Chest; 1977 May; 71(5):640-3. PubMed ID: 852344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.